Clinical Trials Directory

Trials / Completed

CompletedNCT04374617

Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19

Status
Completed
Phase
Study type
Observational
Enrollment
230 (actual)
Sponsor
Hospital Universitari Vall d'Hebron Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Severe COVID-19 patients at a high risk of venous thromboembolism. We studied patients in 2 intensive care units of university hospitals in Barcelona and Badalona, Spain. We performed a cut-off screening of deep venous thrombosis (DVT) with bilateral duplex ultrasound to 230 patients.

Detailed description

SARS-CoV-2 infection has been associated with coagulation disorders and increased risk of venous thromboembolism (VTE). The aim of the study is to determine the cumulative incidence of VTE in critically ill patients with COVID-19 and its impact on prognosis. Methods Cohort study of critically ill patients due to COVID-19. A bilateral venous compression (CUS) ultrasound screening of the lower extremities was performed during a cut-off period in 2 intensive care units of university hospitals in Spain. Asymptomatic and symptomatic VTE were registered: pulmonary embolism (PE) (diagnosed by CT-angiography) and deep venous thrombosis (DVT). The characteristics of the patients, results of their blood tests and their evolution after 7 days of follow-up were recorded.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDuplex ultrasound and Computed Tomography AngiographyAll venous thromboembolisms suspected will diagnosed with ultrasound and CT-angiography

Timeline

Start date
2020-04-01
Primary completion
2020-04-25
Completion
2020-05-01
First posted
2020-05-05
Last updated
2020-05-06

Locations

3 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT04374617. Inclusion in this directory is not an endorsement.